Pilot Trial of Homebound Stem Cell Transplantation

NARecruitingINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Plasma Cell Dyscrasia
Interventions
BEHAVIORAL

Home monitoring teleconsult visits

A tablet will be provided to both the patient and the caregiver during the homecare portion of the study. The tablet will remain at the home, to be used by the patient and the caregiver during daily homecare visits to complete instruments/surveys and video diary recording sessions.

BEHAVIORAL

Patient Reported Outcomes (PRO)

Distress Thermometer, MSK-Modified M.D. Anderson Symptom Inventory (MDASI) Instrument, FACT-G Instrument, FACT-BMT Instrument

BEHAVIORAL

Caregiver Reported Outcomes instruments

Distress Thermometer, Caregiver Reaction Assessment (CRA) Instrument, The Caregiver Quality of Life Index-Cancer (CQOLC) Scale, Satisfaction Questionnaire, Video Diary Entries

Trial Locations (1)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER